Compare Ascendis Pharma A/S (ASND) vs Kaltura Inc (KLTR) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Ascendis Pharma A/S vs Kaltura Inc — how do they compare? Ascendis Pharma A/S trades at $253.76 (market cap $16.67B), while Kaltura Inc trades at $1.63 (market cap $249.42M). The key difference: Ascendis Pharma A/S is far larger — about 66.8× Kaltura Inc's market cap. Which is the better fit depends on your goals.
| ASND | KLTR | |
|---|---|---|
Market Cap | $16.67B | $249.42M |
Sector | Health | Technology |
52-Week High | $277.18 | $1.89 |
52-Week Low | $189.74 | $1.08 |
Enterprise Value | $17.04B | $261.64M |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Ascendis Pharma A/S
Ascendis Pharma A/S is a biopharmaceutical company. It develops prodrug therapies with profiles to address large markets with significant unmet medical needs with its Transcon technology. The firm's product pipeline includes Transcon growth hormone, Transconpeptides, Transcon PTH, Transcon CNP, and others. It operates mainly in North America, Germany, China, and Denmark and derives the majority of its revenue from China.
Read more on ASND →About Kaltura Inc
Kaltura Inc provides live and on-demand video SaaS solutions to thousands of organizations around the world, engaging hundreds of millions of viewers at home, at work, and school. It also offers specialized industry solutions, including Learning Management System Video, Lecture Capture, and Virtual Classroom for educational institutions, as well as a TV Solution for media and telecom companies. It operates in two reporting segments: (i) Enterprise, Education, and Technology (EE&T)
Read more on KLTR →
